In addition, recent evidence has shown that MR1, a nonclassical MHC class I-like molecule, is epigenetically overexpressed in glioma and correlated with poor overall survival and global dysregulation of many immune-related genes [76]. Here, MR1 is linked to central nervous system cancer.